2024-11-29 04:31:31
Alphamab Oncology Announced First Patient Dosed in Phase I Trial of PD-L1/OX40 Bispecific Antibody KN052
Corporate/ 2023-07-24
Alphamab Oncology Announced First Patien...

SUZHOU,China,June 14,2022-- Alphamab Oncology (stock code: 9966.HK)announced thatthe first patient was dosed in a Phase I clinical study (KN...

Farrer Park Hospital Taps on AI to Improve Colorectal Cancer Screening Results
Health/ 2023-07-22
Farrer Park Hospital Taps on AI to Impro...

Enhanced detection allows for higher polyp detection rates and more effective screening for colorectal cancer

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release